Friday, August 1

Rs 50 crore allocated, land identified, but construction still pending

Belagavi – Nearly three years after the announcement of a regional unit of the prestigious Kidwai Cancer Hospital in Belagavi, the project remains stuck on paper. Despite receiving a budgetary allocation of ₹50 crore in the 2022–23 financial year and administrative approvals, no construction activity has taken place so far.

Location Finalised, but No Progress on Ground

Initially proposed to be set up on four acres near the Primary Health Centre in Vadagaon, the location was later shifted to the Belagavi Institute of Medical Sciences (BIMS) premises based on preferences expressed by the hospital authorities. This shift was endorsed by the district administration, and formal administrative approval followed in September 2022.

Political Push Fails to Accelerate Work

MLA Abhay Patil, who represents Belagavi (South), had been instrumental in pushing for the hospital to be set up in his constituency. However, despite his efforts and the project’s sanctioned funds, the proposed unit of the Kidwai Memorial Institute of Oncology has yet to see any actual groundwork begin.

District Minister Promises Action

Acknowledging the prolonged delay, district in-charge minister Satish Jarkiholi stated, “I will check the status of the project and try to start it at the earliest.” His statement offers a glimmer of hope to citizens and cancer patients in the region, who are eagerly awaiting the much-needed facility.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version